2 天之前 · The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram …

1 天前 · The drug, suzetrigine, received the FDA's official stamp of approval Thursday to be sold as a 50-milligram prescription pill taken every 12 hours, according to a press release.

2 天之前 · The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. …

2 天之前 · Journavx is the first drug to be approved in this new class of pain management medicines. Pain is a common medical problem and relief of pain is an important therapeutic …

2 天之前 · The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less.

Up to date information on the latest FDA drug approvals. Includes list of most recent approvals, the conditions approved for, and the approval history.

2 天之前 · The Food and Drug Administration approved a new medication Thursday to treat pain from an injury or surgery. It is expensive, with a list price of $15.50 per pill. But unlike opioid …

2024年12月20日 · What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U.S. See Drugs@FDA for information about all of CDER’s approved drugs …

2025年1月14日 · Several new drugs, vaccines, and OTC products received FDA approval in 2024. Many more will receive approval in 2025. Keep an eye out for the newest drugs and …

2024年11月18日 · In 2023, CDER approved 55 new drugs never before approved or marketed in the U.S., known as “novel” drugs. We also made other important approval decisions, such as …